All Stories

Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab

Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. Pfizer has formed a clinical trial collaboration with Akeso's partner Summit Therapeutics. And more.

Feb 28, 2025 - 14:55
 0
Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab
Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. Pfizer has formed a clinical trial collaboration with Akeso's partner Summit Therapeutics. And more.
Read More

Tags:

Previous Article

'Taking business from Illinois': Work starts soon on $75M air cargo facility at ...

Next Article

What would a UK-US economic deal really look like?

Related Posts

Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod

Fierce Pharma Asia—Novo Nordisk's fraud accusation; Ast...

Feb 21, 2025  0

Bristol Myers Squibb notches overall survival win with Opdivo in pre-operative NSCLC

Bristol Myers Squibb notches overall survival win with ...

Feb 19, 2025  0

AstraZeneca warns of potential tax fines amid China sales slowdown, illegal drug importation probe

AstraZeneca warns of potential tax fines amid China sal...

Feb 9, 2025  0